Treatment of advanced pancreatic adenocarcinoma with 5-FU, leucovorin, interferon-α-2b, and cisplatin

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 20, Issue 1, 1997, Pages 81-83

  Sporn, Jonathan R ^a   Buzaid, Antonio C ^b,c   Slater, Dennis ^a   Cohen, Neil ^d   Greenberg, Bernard R ^a  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

^b YALE CANCER CENTER   (United States)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^d NONE

Author keywords

Cisplatin; Interferon alpha; Pancreatic cancer

Indexed keywords

CISPLATIN; DEXAMETHASONE; DIPHENHYDRAMINE; FLUOROURACIL; FOLINIC ACID; METOCLOPRAMIDE; ONDANSETRON; PARACETAMOL; RECOMBINANT ALPHA2B INTERFERON;

ADULT; ADVANCED CANCER; AGED; ARTICLE; BLOOD TOXICITY; CANCER COMBINATION CHEMOTHERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; DIARRHEA; DOSE RESPONSE; FEMALE; GASTROINTESTINAL TOXICITY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; NAUSEA; NEUTROPENIA; PANCREAS ADENOCARCINOMA; PERIPHERAL NEUROPATHY; PHASE 2 CLINICAL TRIAL; SUBCUTANEOUS DRUG ADMINISTRATION; THROMBOCYTOPENIA; VOMITING;

ADENOCARCINOMA; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CISPLATIN; DRUG ADMINISTRATION SCHEDULE; FEMALE; FLUOROURACIL; HUMANS; INTERFERON ALFA-2B; LEUCOVORIN; MALE; MIDDLE AGED; PANCREATIC NEOPLASMS; SURVIVAL ANALYSIS;

EID: 0031022310     PISSN: 02773732     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000421-199702000-00018     Document Type: Article

References (17)

1. Brennan MF, Kinsella TJ, Casper ES. Cancer of the pancreas. In: Devita VT Jr, Hellman S, Rosenberg SA, eds. Cancer: principles and practice of oncology. 4th ed, Philadelphia: JP Lippincott, 1993:849-82.
2. Wadler S, Schwartz EL. Antineoplastic activity of the combination of interferon and cytotoxic agents against experimental and human malignanciea: A review. Cancer Res 1990;50: 3473-86.
3. Wadler S, Schwartz EL, Goldman M, et al. Fluorouracil and recombinant alfa-2a-interferon: An active regimen against advanced colorectal carcinoma. J Clin Oncol 1989;7:1769-75.
4. Scheithauer W, Pfeffel F, Kornek G, et al. A phase II trial of 5-fluorouracil, leucovorin, and recombinant alpha-2b-interferon in advanced adenocarcinoma of the pancreas. Cancer 1992;70: 1864-6.
5. Pazdur R, Ajani JJ, Abbruzzese JL, et al. Phase II evaluation of fluorouracil and recombinant α-2a-interferon in previously untreated patients with pancreatic adenocarcinoma. Cancer 1992;70:2073-6.
6. Sporn JR, Buzaid A, Slater D, Greenberg BR. Treatment of advanced pancreatic cancer with cisplatin, 5-FU, leucovorin, and interferon α-2b. Proc Am Soc Clin Oncol 1993;12:620.
7. Vokes EE, Ratain MJ, Mick R, et al. Cisplatin, fluorouracil, and leucovorin augmented by interferon alfa-2b in head and neck cancer: a clinical and pharmacologic analysis. J Clin Oncol 1993;11:360-8.
8. Weinerman B, McCormick R. A phase 2 survival comparison of patients with pancreatic cancer treated with 5-fluorouracil and calcium leucovorin compared to matched tumor registry controls. Proc Am Soc Clin Oncol 1992;11:577.
9. Crown J, Casper ES, Botet J, et al. Lack of efficacy of high-dose leucovorin and fluorouracil in patients with advanced pancreatic adenocarcinoma. J Clin Oncol 1991;9:1682-6.
10. Rubin J, Gallagher J, Schutt A, et al. Phase II trials of 5-fluorouracil and leucovorin in patients with metastatic gastric or pancreatic carcinomas. Proc Am Soc Clin Oncol 1992;11:496.
11. Kantarjian H, Ajani JA, Karlin DA. Cis-diaminodichloroplatinum chemotherapy for advanced adenocarcinoma of the upper gastrointestinal tract. Oncology 1985;42:69-71.
12. Rothman H, Cantrell JE Jr, Lokich J, et al. Continuous infusion 5-fluorouracil plus weekly cisplatin for pancreatic carcinoma. Cancer 1991;68:264-8.
13. Andre T, Lotz JP, Bouleuc C, et al. Phase II trial of 5-fluorouracil, folinic acid and cisplatinum in the treatment of advanced pancreatic adenocarcinoma. Proc Am Soc Clin Oncol 1994;13:609.
14. Schneider CJ, Vaughn DJ, Holroyde C, et al. Phase II trial of 5-FU, leucovorin, and interferon alpha 2a in metastatic pancreatic carcomona: A Penn Cancer Clinical Trials Group trial. Proc Am Soc Clin Oncol 1995;14:433.
15. Benasso M, Merlano M, Blengio F, et al. Concomitant alpha-interferon and chemotherapy in advanced squamous cell carcinoma of the head and neck. Am J Clin Oncol 1993;16:465-8.
16. Cascinu S, Fedeli A, Fedeli SL, Catalano G. Cisplatin, 5-fluorouracil, and interferon alpha 2b for recurrent or metastatic head and neck cancer. Br J Cancer 1994;69:392-3.
17. Trudeau M, Zukiwski A, Langleben A, et al. A phase I study of recombinant human interferon alpha-2b combined with 5-fluorouracil and cisplatin in patients with advanced cancer. Cancer Chemother Pharmacol 1995;35:496-500.